
### [MONDO:0006325](http://purl.obolibrary.org/obo/MONDO_0006325)
**Label:** ocular melanoma

**Subclasses:** [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (melanoma, uveal), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), 

**Corr. equiv. classes:** [OMIM:155601](http://purl.obolibrary.org/obo/OMIM_155601), [OMIM:155700](http://purl.obolibrary.org/obo/OMIM_155700), [OMIM:155720](http://purl.obolibrary.org/obo/OMIM_155720), [OMIM:613099](http://purl.obolibrary.org/obo/OMIM_613099), [OMIM:615134](http://purl.obolibrary.org/obo/OMIM_615134), [Orphanet:618](http://www.orpha.net/ORDO/Orphanet_618), [OMIM:613972](http://purl.obolibrary.org/obo/OMIM_613972), [OMIM:615848](http://purl.obolibrary.org/obo/OMIM_615848), [OMIM:606661](http://purl.obolibrary.org/obo/OMIM_606661), [OMIM:606660](http://purl.obolibrary.org/obo/OMIM_606660), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [OMIM:609048](http://purl.obolibrary.org/obo/OMIM_609048), [Orphanet:39044](http://www.orpha.net/ORDO/Orphanet_39044), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 48.72%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 48.72%
- [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 43.21%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 42.11%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 42.11%
- [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 36.70%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 35.00%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 30.42%
- Thing 28.27%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.27%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 27.22%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 27.03%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 24.33%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) 21.45%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 20.71%


